Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes. [electronic resource]
Producer: 20100728Description: E77-84 p. digitalISSN:- 1525-1594
- Adult
- Aged
- Antigens, CD -- metabolism
- Antigens, Differentiation, T-Lymphocyte -- metabolism
- CD28 Antigens -- metabolism
- CD4-Positive T-Lymphocytes -- drug effects
- CD40 Ligand -- metabolism
- Cell Proliferation -- drug effects
- Cells, Cultured
- Epoetin Alfa
- Erythropoietin -- therapeutic use
- Female
- Flow Cytometry
- Hematinics -- therapeutic use
- Humans
- Immunologic Factors -- therapeutic use
- Immunophenotyping -- methods
- Kidney Failure, Chronic -- blood
- Kinetics
- Lectins, C-Type -- metabolism
- Lymphocyte Activation -- drug effects
- Male
- Middle Aged
- Phenotype
- Recombinant Proteins
- Renal Dialysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.